Dabur India gains on expanding Hajmola digestive portfolio by introducing 'Hajmola LimCola'

13 Sep 2021 Evaluate

Dabur India is currently trading at Rs. 642.00, up by 3.75 points or 0.59% from its previous closing of Rs. 638.25 on the BSE.

The scrip opened at Rs. 642.00 and has touched a high and low of Rs. 649.15 and Rs. 637.20 respectively. So far 33328 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 650.90 on 07-Sep-2021 and a 52 week low of Rs. 479.20 on 24-Sep-2020.

Last one week high and low of the scrip stood at Rs. 650.90 and Rs. 627.15 respectively. The current market cap of the company is Rs. 113169.33 crore.

The promoters holding in the company stood at 67.36%, while Institutions and Non-Institutions held 25.25% and 7.38% respectively.

Dabur India has expanded Hajmola digestive portfolio by introducing 'Hajmola LimCola'. The launch will be supported across print, digital, outdoor, mobile, and radio campaigns, featuring Bollywood actor Ajay Devgn. Hajmola LimCola is a digestive tablet with a mix of lemon along with the twist of Hajmola.

This innovation is in line with company’s ambition of providing its consumers their favorite Hajmola with Lemon Ka Chatkara. As per its strategy, Dabur will be undertaking extensive sampling activities through delivery platforms and major restaurant chains, besides Dabbawalas in Mumbai, Airlines, and at key Bus depots.

Dabur India is one of the largest FMCG Company in India.

Dabur India Share Price

510.10 8.20 (1.63%)
23-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Hindustan Unilever 2339.30
Godrej Consumer Prod 1074.10
Dabur India 510.10
Colgate Palmol. (I) 2727.45
P&G Hygiene 14923.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.